Galena Biopharma Announces Closing of Public Offering of Common Stock and … – Nasdaq

Galena Biopharma Announces Closing of Public Offering of Common Stock and
Nasdaq
The underwriters also exercised their over-allotment option to purchase warrants to purchase an aggregate of 1,826,923 shares of common stock. The warrants are immediately exercisable and expire on the fifth anniversary of the date of issuance. The

and more

…read more

About The Author

error: Content is protected !!